AAD 2026Abstract 71239
Successful management of pembrolizumab-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap with upadacitinib
Goetz L, Wang B
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Drug reactions
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.1658 · Not in PubMed: details from Crossref